Cytokinetics, Incorporated (HAN:KK3A) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Wendall Wierenga Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Concert Pharmaceuticals Inc (Director · Mar 13, 2014 – Jun 14, 2018 · Past); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); Santarus Inc (EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past); XenoPort Inc (Director · May 7, 2009 – Jul 5, 2016 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past) | Director · Since at least Feb 9, 2011 |
| Lynne Parshall Other companies: Foghorn Therapeutics Inc. (Director, Ionis Pharmaceuticals · Since at least Aug 16, 2022); Ionis Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2006); Akcea Therapeutics Inc (Director · Jul 13, 2017 – Oct 12, 2020 · Past); Regulus Therapeutics Inc (Director · Oct 4, 2012 – Nov 3, 2014 · Past); Cardiodynamics International Corp (Director · Jul 20, 2006 – Aug 14, 2009 · Past) | Director · Since at least Feb 7, 2013 |
| Santo J Costa Other companies: Aquestive Therapeutics, Inc. (Director · Jul 24, 2018 – Jun 20, 2024 · Past); Osi Pharmaceuticals Inc (Director · Jun 14, 2006 – Jun 7, 2010 · Past); CV Therapeutics Inc (Director · Jun 6, 2006 – Apr 14, 2009 · Past); NPS Pharmaceuticals Inc (Director · Jan 17, 2006 – May 22, 2007 · Past) | Director · Nov 1, 2010 – May 15, 2024 · Past |
| Edward M. Kaye Other companies: Avidity Biosciences, Inc (Director · Since at least Jun 11, 2020); Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019); Sarepta Therapeutics, Inc. (Chair of Scientific Advisory Board · Apr 24, 2012 – Nov 4, 2026 · Past) | Director · Since at least May 18, 2016 |
| James Daly Other companies: Halozyme Therapeutics, Inc. (Director · Since Sep 30, 2026); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 20, 2025); ACADIA Pharmaceuticals Inc. (Director · Since at least May 29, 2025) | Director · Since at least Aug 19, 2025 |
| Muna Bhanji Other companies: Intellia Therapeutics, Inc. (Independent Director · Since at least Apr 28, 2022); Veracyte, Inc. (Director · Since at least Mar 19, 2021); Ardelyx, Inc. (Director · Since at least Mar 11, 2021) | Director · Since at least Feb 17, 2021 |
| Robert E. Landry Other companies: Theravance Biopharma, Inc. (Director · Since at least Nov 5, 2026); Zymeworks Inc. (Director · Since at least Aug 10, 2025); Regeneron Pharmaceuticals, Inc. (EVP Finance CFO · Mar 31, 2022 – Feb 2, 2024 · Past) | Director · Since at least Feb 10, 2025 |
| Sung Lee Other companies: Tango Therapeutics, Inc. (Executive Vice President and Chief Financial Officer, Cytokinetics · Since at least Jan 2, 2026); Vir Biotechnology, Inc. (EVP & Chief Financial Officer · Mar 27, 2023 – Mar 27, 2024 · Past); Sangamo Therapeutics, Inc. (EVP, Chief Financial Officer · Oct 31, 2019 – Nov 25, 2020 · Past) | EVP, Chief Financial Officer · Since at least Apr 26, 2024 |
| Caryn Gordon McDowell Other companies: Quince Therapeutics, Inc. (Chief Legal & Adm. Officer · May 5, 2020 – Jun 6, 2022 · Past); Revance Therapeutics, Inc. (SVP, GC & Secretary · May 1, 2018 – Feb 15, 2020 · Past) | GC & Chief Compliance Officer · May 18, 2016 – Feb 27, 2018 · Past |
| Peter S Roddy Other companies: Filana Therapeutics, Inc. (Chief Financial Officer · May 1, 2010 – Apr 8, 2016 · Past); Aspira Women's Health Inc. (Director · Feb 18, 2010 – Mar 17, 2016 · Past) | SVP Finance & CAO · Feb 8, 2018 – Feb 27, 2018 · Past |
| Robert Califf Other companies: Centessa Pharmaceuticals PLC (Director · May 27, 2021 – May 27, 2021 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 27, 2014 · Past) | Director · Feb 8, 2018 – Jan 3, 2022 · Past |
| Sharon Barbari Other companies: VYNE Therapeutics Inc. (Director · Since at least Jul 19, 2021); Sonoma Pharmaceuticals, Inc. (Director · Mar 26, 2014 – Mar 1, 2018 · Past) | EVP, Finance & CFO · Mar 1, 2006 – Feb 28, 2017 · Past |
| Wendell Wierenga Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jun 18, 2026); Dermata Therapeutics, Inc. (Director · Since at least Aug 12, 2021) | Director · Since at least Oct 15, 2025 |
| Bonnie Charpentier Other companies: Genitope Corp (VP of Regulatory Affairs · Dec 31, 2005 – Apr 27, 2006 · Past) | SVP Regulatory & Compliance · Jan 2, 2014 – Feb 28, 2017 · Past |
| Brett A Pletcher Other companies: Gilead Sciences, Inc. (EVP,Corp Affairs & Gen Counsel · May 9, 2018 – Jun 10, 2022 · Past) | EVP, Chief Legal Officer · Aug 13, 2024 – Aug 30, 2024 · Past |
| Fady I. Malik Other companies: Rocket Pharmaceuticals, Inc. (Independent Director · Since at least Mar 10, 2022) | EVP, Research & Development · Since at least Jun 1, 2012 |
| Jeff Hessekiel Other companies: Exelixis, Inc. (EVP & General Counsel · May 15, 2025 – May 15, 2025 · Past) | Chief Legal & Admin Officer · Since at least Nov 13, 2025 |
| Mark A Schlossberg Other companies: Impax Laboratories Inc (SVP and General Counsel · Feb 26, 2018 – May 4, 2018 · Past) | SVP - Legal & General Counsel · Jan 14, 2019 – Mar 15, 2022 · Past |
| Michael Rabson Other companies: Maxygen Inc (Senior Vice President · Jan 3, 2006 – Feb 1, 2008 · Past) | SVP Business Dev/Legal & GC · Mar 31, 2008 – Dec 18, 2009 · Past |
| Andrew A Wolff | SVP & CMO · Mar 1, 2006 – Feb 28, 2017 · Past |
| Andrew Callos | EVP, Chief Commercial Officer · Since at least Mar 15, 2021 |
| Bradley Paul Morgan | SVP Drug Discovery & Early Dev · Nov 16, 2015 – Aug 31, 2017 · Past |
| Ching Jaw | SVP Finance & CFO · Jun 26, 2017 – Mar 6, 2023 · Past |
| Diane Weiser | SVP, Corporate Affairs · Since at least Nov 3, 2026 |
| Elisabeth A. Schnieders | SVP, Business Development · Since at least Nov 5, 2026 |
| Isaac Ciechanover | EVP, Corporate Development & Chief Business Officer · Since at least Nov 5, 2026 |
| John Faurescu | SVP, Deputy General Counsel & Corporate Secretary · Since at least Nov 5, 2026 |
| John T. Henderson | Director · Since at least Apr 15, 2025 |
| Nancy J. Wysenski | Director · Since at least Apr 15, 2026 |
| Robert A. Harrington | Director · Since at least Apr 8, 2022 |
| Robert I. Blum | President & CEO, Director · Since at least Apr 1, 2026 |
| Robert Wong | VP, Chief Accounting Officer · May 15, 2019 – Dec 3, 2024 · Past |
| Sandford D Smith | Director · Apr 1, 2022 – Jan 2, 2024 · Past |
| Stephen B. Heitner | SVP, Chief Medical Officer · Since at least Oct 12, 2026 |
| Tricia Ottaviani | SVP, U.S. & Global Marketing and Operations · Since at least Nov 5, 2026 |